Actualizaciones en cáncer de próstata

Viola Alles, Alberto J; Musé Sevrini, Ignacio M M.
Arch. med. interna (Montevideo) ; 13(2): 49-56, 1997.
Artículo en Español | URUCAN | ID: bcc-1701

Documentos relacionados

  1. Impact of Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography on the Therapeutic Decision of Prostate Carcinoma Primary Staging: A Retrospective Analysis at the Brazilian National Public Health System.
  2. Carcinoma-associated fibroblasts: orchestrating the composition of malignancy.
  3. Performance of systematic, MRI-targeted biopsies alone or in combination for the prediction of unfavourable disease in MRI-positive low-risk prostate cancer patients eligible for active surveillance.
  4. Innervation density and types of nerves in prostate cancer.
  5. Integration of incomplete multi-omics data using Knowledge Distillation and Supervised Variational Autoencoders for disease progression prediction.
  6. Evaluation of CD47 in the Suppressive Tumor Microenvironment and Immunotherapy in Prostate Cancer.
  7. Intraocular metastasis as a systemic presentation of neuroendocrine differentiation of prostate carcinoma.
  8. [Personalised medicine and interdisciplinarity : A reality in the diagnosis and treatment of primary prostate carcinoma].
  9. Molecular mechanisms and genetic alterations in prostate cancer: From diagnosis to targeted therapy.
  10. Advances in the treatment of malignant ascites in China.